The incretin approach for diabetes treatment: modulation of islet hormone release by GLP-1 agonism.

Medicin og biovidenskab

• Incretins 100%
• Glucagon-Like Peptide 1 90%
• Insulin Secretion 57%
• Hormones 54%
• Glucose 48%
• Peptides 36%
• Dipeptidyl Peptidase 4 25%
• Dipeptidyl-Peptidase IV Inhibitors 25%
• Nonesterified Fatty Acids 20%
• Intravenous Administration 18%
• Insulin Resistance 15%
• Type 2 Diabetes Mellitus 14%
• Body Weight 13%
• Clinical Studies 13%
• Therapeutics 12%
• Gene Expression 11%
• Enzymes 10%
• Growth 9%